Date Initiated by Firm | October 11, 2011 |
Date Posted | August 20, 2012 |
Recall Status1 |
Terminated 3 on March 14, 2013 |
Recall Number | Z-2227-2012 |
Recall Event ID |
62791 |
510(K)Number | K940833 K955435 K973966 |
Product Classification |
Radioimmunoassay, total triiodothyronine - Product Code CDP
|
Product | Access Total T3 Reagent, PN: 33830
The Access Total T3 assay is used for the quantitative determination of triiodothyronine (T3) levels in human serum and plasma in the assessment of thyroid function and diagnosis of thyroid disorders when T3 levels are between 0.1 and 8.0 ng/mL. |
Code Information |
All Lots |
Recalling Firm/ Manufacturer |
Beckman Coulter Inc. 250 S Kraemer Blvd Brea CA 92821-6232
|
Manufacturer Reason for Recall | A recall was initiated because Beckman Coulter has identified a negative bias in test results when comparing elevated Total T3 patient samples diluted with Sample Diluent A to samples diluted with Access Total T3 Calibrator S0. |
FDA Determined Cause 2 | Device Design |
Action | Beckman Coulter sent a Product Correction letter dated October 11, 2011, to all affected customers. The PCA letter informed the customers of the problem identified and the actions to be taken. Customers were informed to stop SDA usage as an alternative dilutent and that the S0 dilutent is to be used for manual dilution of the patient sample for Total T3. They will also be informed to no longer use the On Board Dilution (OBD) option for Total T3. Customers were instructed to complete and return the enclosed response form within 10 days. Customers with questions regarding this notification were instructed to contact Customer Support Center at http://www.beckmancoulter.com/customersupport/support or call (800) 854-3633 in the US and Canada. Outside of the US and Canada, customers were instructed to contact their local Beckman Coulter Representative.
For questions regarding this recall call 714-961-4941. |
Quantity in Commerce | 117,385 units total (33,918 units in US) |
Distribution | Worldwide Distribution - USA (nationwide), Canada, and internationally. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = CDP 510(K)s with Product Code = CDP
|